Czech Republic - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, Czech Republic Hospital Average Length of Stay for Malignant Neoplasm of Prostate was down by 2.2% year on year. At 7.6 Days in 2019, the country was number 9 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate. South Korea ranked the highest with 15.9 Days in 2019, stable versus 2018. New Zealand, Lithuania and Slovakia respectively ranked number 2, 3 and 4 in this ranking. New Zealand recorded the best 5 years average growth at +2.2% per year, while Mexico recorded the worst performance at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 7.60 |
| 2018 | 7.90 |
| 2017 | 7.80 |
| 2016 | 7.90 |
| 2015 | 7.90 |
Download all data from 2000 to 2019
How does Czech Republic rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data | |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data | |
| 8 |
#8
Latvia
|
8.30 | 2019 | -1.2 % | -1.6 % | View data | |
| 9 |
#9
Czech Republic
|
7.60 | 2019 | -3.8 % | -2.2 % | View data | |
| 9 |
#9
Finland
|
7.60 | 2019 | +0.0 % | -4.0 % | View data | |